Skip to Main Content

Paper Details

Target engagement analysis and link to pharmacodynamic endpoint for a novel class of CNS-penetrant and efficacious p38α MAPK inhibitors.
J Neuroimmune Pharmacol
11
2014

Datasets

Release 1.2